Zenith Health Care Ltd Stock Price Today (NSE: ZENITHHE)
Fundamental Score
Zenith Health Care Ltd Share Price Live NSE/BSE & Institutional Fundamental Analysis
Zenith Health Care Ltd share price today is ₹3.30, up +0.00% on NSE/BSE as of 20 February 2026. Zenith Health Care Ltd (ZENITHHE) is a Small-cap company in the Pharmaceuticals sector with a market capitalisation of ₹19.72 (Cr). The 52-week high for ZENITHHE share price is ₹N/A and the 52-week low is ₹N/A. The company has a Return on Equity (ROE) of 0.81% and a debt-to-equity ratio of 0.00.
Zenith Health Care Ltd Share Price Chart — NSE/BSE Historical Performance
Returns & Performance
ROE
ROCE
OPM (5Y)
Div Yield
Zenith Health Care Ltd Valuation Check
P/E Ratio
Industry P/E
Market Cap
Growth Engine
Profit Growth (Q)
Sales Growth (Q)
Sales Growth (5Y)
EPS Growth (5Y)
Profit Growth (5Y)
Balance Sheet Health
Debt to Equity
Int. Coverage
Free Cash Flow (5Y)
Shareholding
Promoter
FII
DII
Pledged
Institutional Deep-Dive
Bull Run Research Hub
Zenith Health Care Share Price: A Financial Analysis
A crucial trend in the pharmaceutical industry is the increasing pressure on pricing and profit margins due to generic drug competition and stringent regulatory oversight. This analysis examines the financial stability of Zenith Health Care Ltd, focusing on its current valuation and operational efficiency. The current Zenith Health Care share price stands at ₹3.37. A key observation is the absence of a Price-to-Earnings (PE) ratio, which can indicate that the company is currently not profitable or has negative earnings.
One of the primary metrics we are reviewing is Zenith Health Care's Return on Capital Employed (ROCE), which is reported at 3.12%. ROCE is a critical indicator of how efficiently a company is using its capital to generate profits. A ROCE of 3.12% suggests that Zenith Health Care is generating relatively low returns on its investments. This low ROCE directly impacts the company's "moat" or competitive advantage. A higher ROCE typically allows a company to reinvest profits more effectively, creating a stronger moat by funding innovation, expanding operations, or acquiring competitors. Conversely, a low ROCE limits these opportunities, potentially weakening the company's competitive position over time.
Comparing Zenith Health Care with its peers provides further context.
Mankind Pharma Ltd is often cited for its relatively strong management quality and efficient operations, which translates into higher profitability metrics. While a direct comparison would require a more in-depth analysis of management strategies and operational efficiencies, the disparity in financial performance between Zenith Health Care and companies like Mankind Pharma Ltd may warrant further investigation into Zenith's operational and strategic decision-making processes.This analysis is part of a comprehensive 80-parameter fundamental audit, verified by Sweta Mishra, to assess the long-term financial health of Zenith Health Care Ltd. The observations presented here are based on publicly available financial data and market information. This analysis does not constitute financial advice, and no buy or sell recommendations are implied.
Labels (e.g., "Excellent", "Good") are peer-based vs industry/sector averages — data-only, not advice
Zenith Health Care Ltd Fundamental Analysis & Valuation Benchmarking
Educational evaluation of ZENITHHE across key market metrics for learning purposes.
Positive Indicators
3 factors identified
Robust Profit Growth (55.56%)
Observation: Strong year-over-year profit expansion demonstrates business momentum.
Analysis: Profit growth >20% indicates effective execution and market opportunity capture.
Debt-Free Balance Sheet (D/E: 0.00)
Observation: Low leverage provides financial flexibility and reduced risk.
Analysis: Conservative debt structure offers resilience during economic downturns.
Zero Share Pledging Risk
Observation: No promoter shares pledged as collateral.
Analysis: Absence of share pledging eliminates potential forced-selling pressure.
Risk Factors
10 factors identified
Below-Average Return on Equity (0.81%)
Observation: Returns on equity are below industry benchmarks.
Analysis: ROE <10% may indicate inefficient capital utilization. Consider monitoring for operational improvements and management effectiveness.
Suboptimal ROCE (3.12%)
Observation: Returns on capital employed are below expectations.
Analysis: ROCE <10% suggests potential inefficiencies in capital allocation.
Margin Pressure Concerns (1.56%)
Observation: Operating margins are below industry standards.
Analysis: OPM <5% may indicate pricing pressures or cost management challenges.
Revenue Contraction (-25.08%)
Observation: Sales decline may indicate market challenges or competitive pressures.
Analysis: Negative revenue growth requires analysis of market conditions.
Limited Growth History (-1.11% CAGR)
Observation: Below-average 5-year sales growth trajectory.
Analysis: Low sales CAGR may indicate mature markets or limited growth opportunities.
Weak Earnings Growth (-36.25% CAGR)
Observation: Below-average 5-year EPS growth performance.
Analysis: Low EPS growth may not keep pace with inflation.
Stagnant Profit Growth (-36.25% CAGR)
Observation: Limited 5-year profit growth trajectory.
Analysis: Low profit growth may indicate scalability challenges or market maturity.
Low Promoter Commitment (28.74%)
Observation: Reduced promoter stake may indicate limited confidence.
Analysis: Low promoter holding may raise questions about management commitment.
Limited Institutional Interest (FII+DII: 0.39%)
Observation: Low institutional participation may affect liquidity.
Analysis: Limited institutional interest may indicate size constraints or visibility issues.
No Dividend Distribution
Observation: Company does not currently pay dividends to shareholders.
Analysis: Zero dividend yield may indicate growth reinvestment focus or cash flow constraints.
Zenith Health Care Ltd Financial Statements
Comprehensive financial data for Zenith Health Care Ltd including income statement, balance sheet and cash flow
About ZENITHHE (Zenith Health Care Ltd)
Zenith Health Care Ltd (ZENITHHE) is listed on the National Stock Exchange (NSE) and Bombay Stock Exchange (BSE) of India. The company operates in the Pharmaceuticals sector with a current market capitalisation of ₹19.72 (Cr). Zenith Health Care Ltd has delivered a Return on Equity (ROE) of 0.81% and a ROCE of 3.12%. The debt-to-equity ratio stands at 0.00, reflecting the company's capital structure. Investors tracking ZENITHHE share price can monitor key metrics including P/E ratio, promoter holding of 28.74%, and quarterly earnings growth.
Company Details
Key Leadership
ZENITHHE Share Price: Frequently Asked Questions
What is the current share price of Zenith Health Care Ltd (ZENITHHE)?
As of 20 Feb 2026, 06:31 am IST, Zenith Health Care Ltd share price is ₹3.30. The ZENITHHE stock has a market capitalisation of ₹19.72 (Cr) on NSE/BSE.
Is ZENITHHE share price Overvalued or Undervalued?
ZENITHHE share price is currently trading at a P/E ratio of 0.00x, compared to the industry average of 31.77x. Based on this relative valuation, the Zenith Health Care Ltd stock appears to be Fairly Valued against its sector peers.
What is the 52-week high and low of ZENITHHE share price?
The 52-week high of ZENITHHE share price is ₹N/A and the 52-week low is ₹N/A.
What factors affect the Zenith Health Care Ltd share price?
Key factors influencing ZENITHHE share price include quarterly earnings growth (Sales Growth: -25.08%), raw material costs, government infrastructure spending, and institutional flows (FII/DII holding).
Is Zenith Health Care Ltd a good stock for long-term investment?
Zenith Health Care Ltd shows a 5-year Profit Growth of -36.25% and an ROE of 0.81%. Long-term investors should consider these fundamentals alongside the debt-to-equity ratio of 0.00 before investing in ZENITHHE shares.
How does Zenith Health Care Ltd compare with its industry peers?
Zenith Health Care Ltd competes with major peers in the Pharmaceuticals. Investors should compare ZENITHHE share price P/E of 0.00x and ROE of 0.81% against the industry averages to determine competitive standing.
What is the P/E ratio of ZENITHHE and what does it mean?
ZENITHHE share price has a P/E ratio of N/Ax compared to the industry average of 31.77x. Investors pay ₹N/A for every ₹1 of annual earnings.
How is ZENITHHE performing according to Bull Run's analysis?
ZENITHHE has a Bull Run fundamental score of 9.5/100, indicating concerns requiring careful analysis. This comprehensive rating is based on 15+ financial parameters.
What sector and industry does ZENITHHE belong to?
ZENITHHE operates in the Pharmaceuticals industry. This classification helps understand the competitive landscape and sector-specific trends affecting Zenith Health Care Ltd share price.
What is Return on Equity (ROE) and why is it important for ZENITHHE?
ZENITHHE has an ROE of 0.81%, which suggests challenges in generating returns from shareholders equity. ROE measures how efficiently Zenith Health Care Ltd generates profits from shareholders capital.
How is ZENITHHE debt-to-equity ratio and what does it indicate?
ZENITHHE has a debt-to-equity ratio of 0.00, which indicates conservative financing with low financial risk.
What is ZENITHHE dividend yield and is it a good dividend stock?
ZENITHHE offers a dividend yield of 0.00%, meaning you receive ₹0.00 annual dividend for every ₹100 invested in Zenith Health Care Ltd shares.
How has ZENITHHE share price grown over the past 5 years?
ZENITHHE has achieved 5-year growth rates of: Sales Growth -1.11%, Profit Growth -36.25%, and EPS Growth -36.25%.
What is the promoter holding in ZENITHHE and why does it matter?
Promoters hold 28.74% of ZENITHHE shares, with 0.00% pledged. High promoter holding often indicates strong management confidence in Zenith Health Care Ltd.
What is ZENITHHE market capitalisation category?
ZENITHHE has a market capitalisation of ₹20 crores, placing it in the Small-cap category.
How volatile is ZENITHHE stock?
ZENITHHE has a beta of N/A. A beta > 1 suggests the Zenith Health Care Ltd stock is more volatile than the market, while a beta < 1 suggests it is less volatile.
What is ZENITHHE operating profit margin trend?
ZENITHHE has a 5-year average Operating Profit Margin (OPM) of 1.56%, indicating the company's operational efficiency.
How is ZENITHHE quarterly performance?
Recent quarterly performance shows Zenith Health Care Ltd YoY Sales Growth of -25.08% and YoY Profit Growth of 55.56%.
What is the institutional holding pattern in ZENITHHE?
ZENITHHE has FII holding of 0.00% and DII holding of 0.39%. Significant institutional holding often suggests professional confidence in the Zenith Health Care Ltd stock.